AI Terminal
Novonesis AS
Director's Dealing • Feb 5, 2021
3377_rpt_2021-02-05_ccfb4735-e2f3-42d8-91be-2730d1efc059.pdf
Director's Dealing
Open in ViewerOpens in native device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
| Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|
| Name | Kasim Kutay | +45 3077 8682 | |
| Reason for notification | Carl Ahlgren | ||
| Position/status | Board member of Novozymes | ||
| Initial notification/ amendment |
Amendment to Company announcement No. 03, 2021 The previously disclosed number of shares (653 shares) were purchased partly by Kasim Kutay (217 shares) and partly by Maha Kutay (436 shares), wife of Kasim Kutay |
Ulrik Wu Svare |
Details of the issuer
| Entity | Novozymes A/S | |
|---|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
Details of the transaction(s)
| Description: | ||||
|---|---|---|---|---|
| Financial instrument | Shares | |||
| Identification code | ISIN DK0060336014 | |||
| Nature of the transaction | Purchase of shares | |||
| Place(s) of transaction(s), | ||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | |
| OMX Copenhagen | 378 | 217 shares | ||
| Aggregated information | Number of shares: 217 | |||
| Average price, DKK: 378 | ||||
| Transaction value, DKK: 82,026 | ||||
| Date of the transaction | 2021-02-03 |
February 5, 2021 Company announcement No. 04
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
+1 919 702 6144 [email protected]
Ulrik Wu Svare +45 3077 3187 [email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Details of the person discharging managerial responsibilities/person closely associated
| Name | Maha Kutay | |||
|---|---|---|---|---|
| Reason for notification | ||||
| Position/status | Wife of Kasim Kutay, Board member of Novozymes | |||
| Initial notification/ | Amendment to Company announcement No. 03, 2021 The previously disclosed number of shares (653 shares) were purchased partly by Kasim Kutay (217 shares) and partly by Maha Kutay (436 shares), wife of Kasim Kutay |
|||
| amendment | ||||
| Details of the issuer | ||||
| Entity | Novozymes A/S | |||
| LEI code | 529900T6WNZXD2R3JW38 | |||
| Details of the transaction(s) | ||||
| Description: | ||||
| Financial instrument | Shares | |||
| Identification code | ISIN DK0060336014 | |||
| Nature of the transaction | Purchase of shares | |||
| Place(s) of transaction(s), | ||||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) | |
| OMX Copenhagen | 378 | 436 shares | ||
| Aggregated information | Number of shares: 436 | |||
| Average price, DKK: 378 Transaction value, DKK: 164,808 |
Date of the transaction 2021-02-03